| Nov 29, 2011
| 4:22 PM
The nation's largest-selling pharmaceutical is going generic this week. Lipitor, which is prescribed to help people reduce their cholesterol levels, is going "off-patent" Wednesday. According to a HealthDay News report, Lipitor sales were nearly $4 billion fro
| Mar 12, 2010
| 4:32 PM
The Food and Drug Administration said Friday that it will require a new black-box warning on the label of the popular anti-clotting drug Plavix to indicate that some patients do not metabolize the drug properly and may receive little benefit...
| Mar 3, 2014
| 6:24 AM
MUMBAI (Reuters) - Indian drugmaker Lupin Ltd is seeking new partnership agreements as it moves into the promising fields of inhaled lung drugs and copies of biotechnology drugs, its managing director said.
The United States and Japan were the most...
| Feb 17, 2014
| 11:02 PM
* Draft law to publish discounts agreed with drugmakers
* Dozens of countries use German drug prices as reference
* More drugmakers could opt not to launch drugs in Germany
By Ludwig Burger and Thorsten Severin
FRANKFURT/BERLIN, Feb 18 (Reuters) -...
| Feb 6, 2014
| 1:28 AM
By Sumeet Chatterjee and Ben Hirschler
MUMBAI/LONDON, Feb 6 (Reuters) - Global pharmaceutical firms
are pressuring the United States to act against India to stop
more local companies producing up to a dozen new varieties of
cheap generic drugs still on-...